{
    "clinical_study": {
        "@rank": "142793", 
        "arm_group": {
            "arm_group_label": "Viscoelastic properties of the airway", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "In obstructive sleep apnea (OSA), the upper airway recurrently closes during sleep. The\n      mechanisms that lead to airway closure are not completely understood. Some studies have\n      shown that there is progressive narrowing of the pharyngeal airway across breaths during\n      expiration (Progressive Expiratory Narrowing, PEN) preceding an obstructive apnea. The\n      investigators will assess the viscoelastic properties of the pharyngeal airway and its role\n      in PEN."
        }, 
        "brief_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "In obstructive sleep apnea, the upper airway recurrently closes during sleep. The mechanisms\n      that lead to airway closure are not completely understood. Some studies have shown that\n      there is progressive narrowing of the pharyngeal airway across breaths during expiration\n      (Progressive Expiratory Narrowing, PEN) preceding an obstructive apnea.\n\n      The investigators will test how the viscoelastic properties of the airway influence PEN. To\n      this end, the investigators will visualize the pharynx of sleep apnea patients using a thin\n      endoscope and will induce central apneas during sleep. Pharyngeal cross-sectional area will\n      be recorded during incremental changes in pharyngeal pressure during  central apneas."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal subjects or patients with OSA\n\n        Exclusion Criteria:\n\n          -  Any unstable cardiac condition (other than well controlled hypertension) or pulmonary\n             problems.\n\n          -  Any medication known to influence breathing, sleep/arousal or muscle physiology\n\n          -  Concurrent sleep disorders (insomnia, narcolepsy, central sleep apnea or parasomnia)\n\n          -  Claustrophobia\n\n          -  Inability to sleep supine\n\n          -  Allergy to lidocaine or oxymetazoline hydrochloride\n\n          -  For women: Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733784", 
            "org_study_id": "2012P000957D", 
            "secondary_id": "1R01HL102321-01A1"
        }, 
        "intervention": {
            "arm_group_label": "Viscoelastic properties of the airway", 
            "intervention_name": "Induced central apneas", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sleep Apnea", 
            "Pathophysiology"
        ], 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "contact": {
                "email": "pgenta@partners.org", 
                "last_name": "Pedro R Genta, MD", 
                "phone": "617-732-6541"
            }, 
            "contact_backup": {
                "email": "lhess1@partners.org", 
                "last_name": "Lauren B Hess, BS", 
                "phone": "(617) 732-8976"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": {
                "last_name": "Pedro R Genta, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D", 
        "overall_contact": {
            "email": "pgenta@partners.org", 
            "last_name": "Pedro R Genta, MD", 
            "phone": "(617) 732-6541"
        }, 
        "overall_contact_backup": {
            "email": "lhess1@partners.org", 
            "last_name": "Lauren B Hess, BS", 
            "phone": "(617) 732-8976"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "David A Wellman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators will determine elasticity of the upper airway during induced central apneas by dividing the change in airway pressure by the change in airway cross-sectional area.\nThe time frame for the outcome of this study is equal to the duration of the induced central sleep apnea (usually less than 40 seconds).", 
            "measure": "Upper airway elasticity", 
            "safety_issue": "No", 
            "time_frame": "10 - 40 seconds"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733784"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "David Andrew Wellman", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}